Literature DB >> 24879625

Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.

Enjiao Zhang1, Shuang Liu, Zhongfei Xu, Shaohui Huang, Xuexin Tan, Changfu Sun, Li Lu.   

Abstract

Pituitary tumor-transforming gene 1 (PTTG1) is an important oncogenic transcription factor implicated in various malignancies, including oral squamous cell carcinoma (OSCC), a common malignancy of head and neck. Although PTTG1 is reportedly overexpressed in OSCC tissues, its role in human OSCC remains elusive. Thus, this study was conducted to explore the correlation between PTTG1 expression and tumorigenesis of OSCC. We first examined PTTG1 mRNA and protein expression in 28 pairs of OSCC tissues and adjacent non-tumor tissues. PTTG1 protein levels in 98 OSCC specimens were also evaluated by using immunohistochemistry. Our data showed that both mRNA and protein expression levels of PTTG1 in OSCC tissue specimens were markedly higher than that in the corresponding non-tumor tissue samples. A high level of PTTG1 protein expression was found in 74 out of 98 cases (75.51 %) and it was correlated with lymph node metastasis (P = 0.002) and tumor-node-metastasis (TNM) stage (P = 0.007) of patients with OSCC. Moreover, forced overexpression of PTTG1 enhanced SCC15 cell migration and invasion, whereas knockdown of PTTG1 resulted in reverse phenomena. In addition, elevated PTTG1 also increased the activities and expressions of matrix metalloproteinase (MMP)-2, and enhanced epithelial-mesenchymal-transition (EMT) process in SCC15 cells. The EMT changes were accompanied by downregulation of epithelial cadherin (E-cadherin) protein expression and upregulation of snail and vimentin. In summary, our results illustrate that PTTG1 may contribute to the development and progression of human OSCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24879625     DOI: 10.1007/s13277-014-2143-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  42 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  E-cadherin-catenin cell-cell adhesion complex and human cancer.

Authors:  B P Wijnhoven; W N Dinjens; M Pignatelli
Journal:  Br J Surg       Date:  2000-08       Impact factor: 6.939

3.  Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo.

Authors:  Jung Cho-Rok; Jinsang Yoo; Ye Jin Jang; Sangsoo Kim; In-Sun Chu; Young Il Yeom; Jong Young Choi; Dong-Soo Im
Journal:  Hepatology       Date:  2006-05       Impact factor: 17.425

4.  Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma.

Authors:  Bill Wondergem; Zhongfa Zhang; Dachuan Huang; Choon Kiat Ong; Julie Koeman; David Van't Hof; David Petillo; Aikseng Ooi; John Anema; Brian Lane; Richard J Kahnoski; Kyle A Furge; Bin Tean Teh
Journal:  Cancer Res       Date:  2012-07-17       Impact factor: 12.701

5.  ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.

Authors:  Li-Jie Xiao; Ping Lin; Feng Lin; Xin Liu; Wei Qin; Hai-Feng Zou; Liang Guo; Wei Liu; Shu-Juan Wang; Xiao-Guang Yu
Journal:  Int J Oncol       Date:  2011-12-23       Impact factor: 5.650

6.  PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.

Authors:  Chang-Hwan Yoon; Min-Jung Kim; Hyejin Lee; Rae-Kwon Kim; Eun-Jung Lim; Ki-Chun Yoo; Ga-Haeng Lee; Yan-Hong Cui; Yeong Seok Oh; Myung Chan Gye; Young Yiul Lee; In-Chul Park; Sungkwan An; Sang-Gu Hwang; Myung-Jin Park; Yongjoon Suh; Su-Jae Lee
Journal:  J Biol Chem       Date:  2012-04-16       Impact factor: 5.157

7.  Association of pituitary tumor transforming gene expression with early oral tumorigenesis and malignant progression of precancerous lesions.

Authors:  Li-Jen Liao; Yi-Hsin Hsu; Chuan-Hang Yu; Chun-Pin Chiang; Jing-Ru Jhan; Lien-Cheng Chang; Jing-Jer Lin; Pei-Jen Lou
Journal:  Head Neck       Date:  2010-11-10       Impact factor: 3.147

Review 8.  Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res., 9: 00-00, 2003.

Authors:  Joyce E Rundhaug
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

Review 9.  Transcriptional targets for pituitary tumor-transforming gene-1.

Authors:  Yunguang Tong; Tamar Eigler
Journal:  J Mol Endocrinol       Date:  2009-05-11       Impact factor: 5.098

Review 10.  Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update.

Authors:  Fateme Salehi; Kalman Kovacs; Bernd W Scheithauer; Ricardo V Lloyd; Michael Cusimano
Journal:  Endocr Relat Cancer       Date:  2008-09       Impact factor: 5.678

View more
  13 in total

1.  Increased miR-338-3p expression correlates with invasiveness of GH-producing pituitary adenomas.

Authors:  Yang Jong Lee; Jin Mo Cho; Ju Hyung Moon; Cheol Ryong Ku; Jean Kim; Sun Ho Kim; Eun Jig Lee
Journal:  Endocrine       Date:  2017-08-14       Impact factor: 3.633

2.  Inhibition of metastasis of oral squamous cell carcinoma by anti-PLGF treatment.

Authors:  Jingqiu Bu; Xi Bu; Bing Liu; Fei Chen; Peng Chen
Journal:  Tumour Biol       Date:  2014-11-29

3.  Pituitary tumor-transforming gene 1 regulates invasion of prostate cancer cells through MMP13.

Authors:  Yun-Hua Lin; Yong Tian; Jun-Sheng Wang; Yong-Guang Jiang; Yong Luo; Ya-Tong Chen
Journal:  Tumour Biol       Date:  2015-07-23

4.  MiR-497 enhances metastasis of oral squamous cell carcinoma through SMAD7 suppression.

Authors:  Jun Hu; Jun-Feng Xu; Wei-Li Ge
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

5.  Does securin expression have significance in prognostication of oral tongue cancer? A pilot study.

Authors:  Ilkka Heikkinen; Alhadi Almangush; Jaana Hagström; Ibrahim O Bello; Joonas H Kauppila; Laura K Mäkinen; Caj Haglund; Pentti Nieminen; Tuula Salo; Ilmo Leivo
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-18       Impact factor: 2.503

6.  Expression of proteins associated with epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

Authors:  Tian Zhang; Hao Li; Yang Zhang; Pei Wang; Huijie Bian; Zhi-Nan Chen
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

7.  Alteration of Pituitary Tumor Transforming Gene 1 by MicroRNA-186 and 655 Regulates Invasion Ability of Human Oral Squamous Cell Carcinoma.

Authors:  Sang Shin Lee; Jong Ho Choi; Seung Mook Lim; Gi Jin Kim; Suk Keun Lee; Yoon Kyung Jeon
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

8.  Atractylenolide III inhibits epithelial‑mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway.

Authors:  Mingjin Huang; Wenwen Jiang; Chunli Luo; Min Yang; Yan Ren
Journal:  Mol Med Rep       Date:  2022-01-28       Impact factor: 3.423

9.  Differential transcription profiles of long non-coding RNAs in primary human brain microvascular endothelial cells in response to meningitic Escherichia coli.

Authors:  Ruicheng Yang; Fei Huang; Jiyang Fu; Beibei Dou; Bojie Xu; Ling Miao; Wentong Liu; Xiaopei Yang; Chen Tan; Huanchun Chen; Xiangru Wang
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

10.  Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.

Authors:  Simona Caporali; Ester Alvino; Pedro Miguel Lacal; Federica Ruffini; Lauretta Levati; Laura Bonmassar; Alessandro Scoppola; Paolo Marchetti; Simona Mastroeni; Gian Carlo Antonini Cappellini; Stefania D'Atri
Journal:  Oncotarget       Date:  2017-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.